Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 10/2020

01-10-2020 | COVID-19 | Concise Research Report

Mobility and Mortality During the COVID-19 Pandemic

Authors: Jonathan S. Zipursky, MD, FRCPC, Donald A. Redelmeier, MD, FRCPC, MSHSR, FACP

Published in: Journal of General Internal Medicine | Issue 10/2020

Login to get access

Excerpt

Social distancing and other behavioral interventions help limit the spread of infectious diseases.1 These measures include school closures, cancellations of large gatherings, and travel restrictions.1 We assessed the effectiveness of social distancing during the coronavirus (COVID-19) pandemic by examining the association between reductions in driving distances and mortality rates on an international basis. …
Literature
1.
2.
3.
4.
Tandon A, Murray CJL, Lauer JA, Evans DB. Measuring Overall Health System Performance for 191 Countries. GPE Discussion Paper Series: No. 30. EIP/GPE/EQC. World Health Organization
5.
6.
Metadata
Title
Mobility and Mortality During the COVID-19 Pandemic
Authors
Jonathan S. Zipursky, MD, FRCPC
Donald A. Redelmeier, MD, FRCPC, MSHSR, FACP
Publication date
01-10-2020
Publisher
Springer International Publishing
Keyword
COVID-19
Published in
Journal of General Internal Medicine / Issue 10/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-05943-7

Other articles of this Issue 10/2020

Journal of General Internal Medicine 10/2020 Go to the issue

Original Research

Sexual Harassment of Female Providers by Patients: a Qualitative Study

Perspective

When Disease Strikes Leaders: What Should We Know?

Original Research

“The More They Know, the Better Care They Can Give”: Patient Perspectives on Measuring Functional Status in Primary Care

Concise Research Report

Trends in Ambulatory Electronic Consultations During the COVID-19 Pandemic

Innovations in Clinical Practice

A Model for Rapid Transition to Virtual Care, VA Connecticut Primary Care Response to COVID-19

Original Research

Mobile-Enhanced Peer Support for African Americans with Type 2 Diabetes: a Randomized Controlled Trial
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits